Bala Venkatesh's Publications

About Bala Venkatesh's Publications

Program Director, Critical Care
  • MBBS,
  • MD (Int.Med),
  • FRCA,
  • FFARCSI,
  • MD (UK),
  • FCICM

  • Performance comparison of single and ensemble CNN, LSTM and traditional ANN models for short-term electricity load forecasting

    The Journal of Engineering Date published:

  • Balanced Crystalloids versus Saline in Critically Ill Adults - A Systematic Review with Meta-Analysis

    NEJM Evidence Date published:

  • Incorrect Equivalent Dose and P Values in Figure 3

    JAMA Date published:

  • Balanced Multielectrolyte Solution versus Saline in Critically Ill Adults

    New England Journal of Medicine Date published:

  • Inhibitors of WNT signalling alleviate inflammation in sepsis patients

    Date published:

  • Estimates of Sepsis Prevalence and Outcomes in Adult Patients in the ICU in India

    CHEST Date published:

  • Evaluation of Noise Distributions for Additive and Multiplicative Smart Meter Data Obfuscation

    IEEE Access Date published:

  • A Zonal Capacity Market Model With Energy Storage for Transmission and Distribution

    IEEE Open Access Journal of Power and Energy Date published:

  • Fast SDP Relaxation of the Optimal Power Flow Using the Line-Wise Model for Representing Meshed Transmission Networks

    IEEE Transactions on Power Systems Date published:

  • A practical method to assess the potential of energy storage systems to mitigate voltage sags

    Electric Power Systems Research Date published:

  • Challenges in operationalising clinical trials in India during the COVID-19 pandemic

    The Lancet Global Health Date published:

  • Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

    BMC Infectious Diseases Date published:

  • Infection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi method

    The Lancet Infectious Diseases Date published:

  • Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial

    Intensive Care Medicine Date published:

  • Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia

    JAMA: The Journal of the American Medical Association Date published:

  • Queensland Pediatric Sepsis Breakthrough Collaborative: Multicenter Observational Study to Evaluate the Implementation of a Pediatric Sepsis Pathway Within the Emergency Department

    Critical Care Explorations Date published: